en

PRODUCT DETAIL

Nerlynx 40 mg filmom obalené tablety

Code 9266C
MA number EU/1/18/1311/001
Product Form: tbl flm 180x40 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XE Protein kinase inhibitors
L01XE45 Neratinib
Shelf life: 36
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 31.08.2018
Validity: 31.08.2023
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 18.08.2020
eu-flag.png sk-flag.png